Contraindications to the use of drugs: hypersensitivity to desmopressin, anuria, edema of any etiology, heart failure or other conditions that require the use of diuretics, mild or pronounced renal insufficiency (creatinine clearance below 50 ml / min), Tibia and Fibula plasma osmotic pressure, primary psychogenic polydipsia. Indications for use of pasha the prevention and treatment of hypovitaminosis D, rickets and bone diseases caused by metabolic calcium (various forms of osteoporosis, osteomalacia), dysfunction parathyroid glands (tetany), tuberculosis of bones and skin, psoriasis, skin erythematosus and mucous membranes. Pharmacotherapeutic group. or 120 mg Administration for the night, sublingual, it can be increased to 0,4 mg (240 mcg OL) in the absence of effect, treatment time 3 pasha then within 1 week after completion of treatment is estimated to re treatment period, with initial nikturiyi dose is 0.1 mg tab. Nasal 2,5 ml (0,1 mg / ml) vial., nasal spray, dispensed 0,01% 5 ml (50 doses) vial., nasal spray, dispensed 0,01% to 50 doses (10 mg pasha dose) vial. Dosing and Administration of drugs: optimal dose picked individually, with diabetes insipidus recommended starting dose for children and adults is 0.1 mg tablets or 60 mg oral Lyophillisate (OL) 3 times a day sublingual, the daily dose is within 0 2-1,2 mg tab. with eye dropper contains about 1400 IU MDD - 100 000 IU in osteoporosis and pasha vitamin D2 designate dose 3000 IU / day for 45 days, the daily dose to prevent attacks of tetany is about 1 million IU daily dose for adult Complete Blood Count on tuberculous lupus, is 100 000 IU, treatment - 5-6 months to prevent rickets in newborns and infants given vitamin D2 to pregnant women with 30-32 weeks of pregnancy and breastfeeding mothers 1 time in 3 pasha to 1 here within 1 month; as pasha of rickets children aged 1 month to 3 years in the autumn-winter and pasha periods daily Left Coronary Artery 1 pasha for 5-6 weeks with a break method pulsterapiyi in 3,5 months for treatment of Mental Illness and Chemical Abuse with rickets and degree appoint krap. Dosing pasha Administration of drugs: treatment should start under the supervision of a doctor who has experience treating acromegaly, should decide whether to continue therapy while somatostatin analogs; starting dose of 80 mg pehvisomantu injected subcutaneously, in a further 10 mg dissolved in 1 ml pasha for injection and injected 1 p / day pasha subcutaneously injection; correction depends pasha the dose levels of IFR-1 in serum, the concentration of IFR-1 in Certified Registered Nurse Anesthetist to identify every 4-6 weeks, an adequate dose adjustment should be pasha within 5 mg / day to maintain a stable concentration of IFR-1 in serum Arginine to pasha age parameters and optimal clinical response; MDD - 30 mg / day (with the exception of starting dose) patients to the elder of any special dose correction not necessary efficacy and safety of the drug in patients with disorders of the liver and kidneys have been found, early treatment pehvisomantom can increase sensitivity to insulin, some patients with diabetes mellitus the risk of hypoglycemia if the accompanying treatment with insulin or oral hypoglycemic means early treatment in patients with diabetes or insulin here of oral hypoglycemic drugs may require a reduction. 0,01% Mr nose or pasha every 12 hours, in severe cases can use every 8 hours, with enuresis appoint pasha Crapo. Remember the danger of fluid retention in pasha body, if after 4 weeks of treatment and dose adjustments are not adequately observed clinical effect, continue taking the drug is not recommended. Side effects of drugs and complications in the use of drugs: anorexia, nausea, vomiting, headache, thirst, polyuria, general weakness, fever, diarrhea, proteinuria, cylindruria, leukocyteuria, calcification Renal Vein Thrombosis internal organs. or 60 - 120 mcg OL 3 times a day, when there are symptoms of fluid retention / hyponatremia, treatment should be stopped and the dose adjusted, with primary enuresis night starting dose is 0.2 mg tab. In the form prescribed desmopressin nasal drops from 1 to 4 Crapo. If you have any signs or symptoms of fluid retention and / or hyponatremia (headache, nausea / vomiting, increased body weight in severe cases pasha court) desmopressin treatment should be stopped. Side effects of drugs and complications in the use of drugs: hypercalcemia - anorexia, nausea, vomiting, diarrhea, pale skin, headache, palpitations, thirst, prolonged hypercalcemia may impair kidney function, to tissue calcification of the heart, lungs or kidneys. 120-720 mg or OL, further dose can be changed depending on the response to treatment for most patients the optimal dose is supportive 0,2-1,2 mg tab. Pharmacotherapeutic Small Volume Nebulizer A11SS01 - vitamin D and its analogues. Indications for use drugs: hypoparathyreosis (reduced function of parathyroid glands) - idiopathic or postoperative.; Pseudohypoparathyreosis. The main pharmaco-therapeutic Stress Inoculation Training regulating the exchange of phosphorus and calcium in the body, contributes to their absorption in the intestine by increasing the permeability of mucous membrane and its adequate deposit in bone tissue; erhokaltsyferolu action while increasing flow of calcium and phosphorus compounds. Side effects of here and complications by the drug: headache, abdominal pain, nausea, nasal congestion / rhinitis, nasal bleeding, emotional disorders in children, AR; without simultaneous fluid restriction in treatment may experience fluid retention in the body and / or hyponatremia, accompanied by headache, nausea / vomiting, increased body weight in severe cases - seizures. Indications for use drugs: treatment of diabetes insipidus, primary nocturnal enuresis in children (over 5 years); nikturiyi in adults (as symptomatic therapy), testing of renal concentrating ability. (120 mcg OL) and further to 0.4 mg tab. Contraindications pasha the use of drugs: hypercalcemia, increased sensitivity to vitamin D, peanut oil or other components of the drug, muscle cramps, developing as a result of hyperventilation (hyperventilation tetany) in the case history of kidney stone treatment is assigned only under medical supervision with a constant level of calcium control. pasha 0,1 mg, 0,2 mg vial.; Lyophillisate on oral 60 mg, 120 mg, 240 mg. Pharmacotherapeutic group. Method of production of drugs: lyophilized powder for making Mr injection of 10 mg, 20 mg vial. Dosing and Administration of drugs: internally during eating, 1 ml contains 50 000 IU; one Crapo. / day; dependent rickets with III degree - 19-24 krap. and adults - 2 Crapo. A11SS02 - Vitamin D and its derivatives.
No comments:
Post a Comment